More benefits than any other single probiotic consortium

Lab4P is a blend of five strains of probiotics – the four Lab4 strains with Lactobacillus plantarum (CUL66).
The Lab4P probiotics consortia has been developed and researched over the past five years, to identify its properties, potential mechanisms of action and impact upon weight loss, immunity and general wellbeing. Two major studies, published in three clinical papers to date, have shown a positive impact in all of these areas and this probiotics blend also entrains all the benefits already identified for the original Lab4 consortium.

2016

Lactobacillus plantarum CUL66 and Cholesterol Study

Lactobacillus plantarum CUL66 can impact cholesterol homeostasis in Caco-2 enterocytes

2017

Lab4P and Cholesterol Study

The anti-cholesterolaemic effect of a consortium of probiotics: An acute study in C57BL/6J mice (Part 2)

2020

The PROMAGEN Study: Weight loss and Cholesterol

A randomised controlled study shows supplementation of overweight and obese adults with lactobacilli and bifidobacteria reduces bodyweight and improves well-being

2020

The PROMAGEN Study: URTI Symptoms

A randomised controlled study shows supplementation of overweight and obese adults with lactobacilli and bifidobacteria reduces bodyweight and improves well-being

2020

The PROMAGEN Study: Quality of Life

A randomised controlled study shows supplementation of overweight and obese adults with lactobacilli and bifidobacteria reduces bodyweight and improves well-being

2021

The PROMAGEN Study: Viral pandemic link?

Probiotics reduce self-reported symptoms of upper respiratory tract infection in overweight and obese adults: should we be considering probiotics during viral pandemics?

2021

The PROBE Study

Daily supplementation with the Lab4P probiotic consortium induces significant weight loss in overweight adults

Scroll to Top